ClinicalTrials.Veeva

Menu

Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

H

Hasselt University

Status

Unknown

Conditions

Incidence of Readmissions
ADE's Due to Anticoagulants

Study type

Observational

Funder types

Other

Identifiers

NCT02074085
14.05/APO14.01

Details and patient eligibility

About

An ADE is defined as harm caused by a drug or the inappropriate use of a drug. Retrospective record reviews in several countries have shown that anticoagulants frequently lead to hospital readmissions. In this study a hospital readmission is defined as an admission to the emergency department of the Jessa hospital. The objective of this study is to determine the incidence of one week and 30-day readmissions caused by (preventable) ADE's due to anticoagulants.

Enrollment

450 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients who received an anticoagulant on their last day of admission
  2. Patients who were readmitted within 30 days
  3. Patients who were diagnosed using the pathology registration of the emergency department of the Jessa hospital

Exclusion criteria

  1. Patients who didn't receive an anticoagulant on their last day of admission
  2. Patients who were not readmitted within 30 days
  3. Patients who were not diagnosed using the pathology registration of the emergency department of the Jessa hospital
  4. Patients with missing data

Trial contacts and locations

1

Loading...

Central trial contact

Martijn Droogmans, Ap.; Kristel Marquet, Drs.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems